Laura Besch - Search Results

Year	Number of Results
2018	1
2019	1
2020	2
2021	1
2022	3

1

Bone Scaffolds Based on Degradable Vaterite/PEG-Composite Microgels.

Stengelin E, Kuzmina A, Beltramo GL, Koziol MF, Besch L, Schröder R, Unger RE, Tremel W, Seiffert S. Stengelin E, et al. Among authors: besch l. Adv Healthc Mater. 2020 Jun;9(11):e1901820. doi: 10.1002/adhm.201901820. Epub 2020 May 6. Adv Healthc Mater. 2020. PMID: 32378355

2

Accuracy in risk understanding among BRCA1/2-mutation carriers.

Speiser D, Rebitschek FG, Feufel MA, Brand H, Besch L, Kendel F. Speiser D, et al. Among authors: besch l. Patient Educ Couns. 2019 Oct;102(10):1925-1931. doi: 10.1016/j.pec.2019.05.007. Epub 2019 May 5. Patient Educ Couns. 2019. PMID: 31079956

3

Acid-Cleavable Poly(ethylene glycol) Hydrogels Displaying Protein Release at pH 5.

Ewald J, Blankenburg J, Worm M, Besch L, Unger RE, Tremel W, Frey H, Pohlit H. Ewald J, et al. Among authors: besch l. Chemistry. 2020 Mar 2;26(13):2947-2953. doi: 10.1002/chem.201905310. Epub 2020 Feb 18. Chemistry. 2020. PMID: 31850549 Free PMC article.

4

Making Sense of a Health Threat: Illness Representations, Coping, and Psychological Distress among BRCA1/2 Mutation Carriers.

Brand H, Speiser D, Besch L, Roseman J, Kendel F. Brand H, et al. Among authors: besch l. Genes (Basel). 2021 May 14;12(5):741. doi: 10.3390/genes12050741. Genes (Basel). 2021. PMID: 34069035 Free PMC article.

5

What Causes Cancer in Women with a gBRCA Pathogenic Variant? Counselees' Causal Attributions and Associations with Perceived Control.

Kendel F, Klein K, Schüürhuis S, Besch L, Feufel MA, Speiser D. Kendel F, et al. Among authors: besch l. Genes (Basel). 2022 Aug 6;13(8):1399. doi: 10.3390/genes13081399. Genes (Basel). 2022. PMID: 36011311 Free PMC article.

6

Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center.

Zang B, Helms M, Besch L, Kalmbach N, Stegen S, Blohmer JU, Speiser D. Zang B, et al. Among authors: besch l. Arch Gynecol Obstet. 2022 Oct 28. doi: 10.1007/s00404-022-06819-3. Online ahead of print. Arch Gynecol Obstet. 2022. PMID: 36307613

7

In Vivo Biocompatibility Investigation of an Injectable Calcium Carbonate (Vaterite) as a Bone Substitute including Compositional Analysis via SEM-EDX Technology.

Unger RE, Stojanovic S, Besch L, Alkildani S, Schröder R, Jung O, Bogram C, Görke O, Najman S, Tremel W, Barbeck M. Unger RE, et al. Among authors: besch l. Int J Mol Sci. 2022 Jan 21;23(3):1196. doi: 10.3390/ijms23031196. Int J Mol Sci. 2022. PMID: 35163120 Free PMC article.

8

Particles of vaterite, a metastable CaCO₃ polymorph, exhibit high biocompatibility for human osteoblasts and endothelial cells and may serve as a biomaterial for rapid bone regeneration.

Schröder R, Besch L, Pohlit H, Panthöfer M, Roth W, Frey H, Tremel W, Unger RE. Schröder R, et al. Among authors: besch l. J Tissue Eng Regen Med. 2018 Jul;12(7):1754-1768. doi: 10.1002/term.2703. Epub 2018 Jun 10. J Tissue Eng Regen Med. 2018. PMID: 29770592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results